Bioresorbable Scaffolds: Where Do We Stand Now? (Video)

The key question is what happens long-term

Interest in bioresorbable scaffolds endures despite an excess of adverse outcomes with the Absorb™ bioresorbable scaffold at year 2 of the ABSORB III trial reported at the American College of Cardiology meeting in March (detailed here). In this three-minute video, ABSORB III principal investigator and Cleveland Clinic cardiologist Stephen Ellis, MD, explains why the rationale behind bioresorbable scaffolds remains intact and that the key question is what happens with these devices over the long term.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy